Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML

Menghrajani, K., Gomez-Arteaga, A., Madero-Marroquin, R., Zhang, M.-J., Bo-Subait, K., Sanchez, J., Wang, H.-L., Aljurf, M., Assal, A., Bacher, V. U., Badawy, S. M., Bejanyan, N., Bhatt, V. R., Bredeson, C., Byrne, M., Castillo, P., Cerny, J., Chhabra, S., Ciurea, S. O., … Saber, W. (2022). Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML. Blood Advances, 6(3), 828–847. https://doi.org/10.1182/bloodadvances.2021004881
Authors:
Kamal Menghrajani
Alexandra Gomez-Arteaga
Rafael Madero-Marroquin
Mei-Jie Zhang
Khalid Bo-Subait
Jonathan Sanchez
Hai-Lin Wang
Mahmoud Aljurf
Amer Assal
Vera Ulrike Bacher
Sherif M. Badawy
Nelli Bejanyan
Vijaya Raj Bhatt
Christopher Bredeson
Michael Byrne
Paul Castillo
Jan Cerny
Saurabh Chhabra
Stefan Octavian Ciurea
Zachariah DeFilipp
Nosha Farhadfar
Shahinaz Gadalla
Robert Peter Gale
Siddhartha Ganguly
Lohith Gowda
Michael R. Grunwald
Shahrukh Hashmi
Gerhard Hildebrandt
Christopher G. Kanakry
Ankit Kansagra
Farhad Khimani
Maxwell Krem
Hillard Lazarus
Hongtao Liu
Rodrigo Martino
Fotios V. Michelis
Sunita Nathan
Taiga Nishihori
Richard Olsson
Ran Reshef
David Rizzieri
Jacob M. Rowe
Bipin N. Savani
Sachiko Seo
Akshay Sharma
Melhem Solh
Celalettin Ustun
Leo F. Verdonck
Christopher Hourigan
Brenda Sandmaier
Mark Litzow
Partow Kebriaei
Daniel Weisdorf
Yanming Zhang
Martin S. Tallman
Wael Saber
Affiliated Authors:
Amer Assal
Ran Reshef
Publication Type:
Article
Unique ID:
10.1182/bloodadvances.2021004881
PMID:
Journal:
Publication Date:
Data Source:
Scopus

Record Created: